Parmax Pharma
PARMAX · Pharma > Pharmaceuticals & Drugs Listing date: March 17, 2017

Stock Price vs Company Growth
1d
2.1%
1w
12.0%
1m
11.2%
3m
17.5%
6m
39.0%
1y
22.7%
5y
17.2%
all
16.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 40.5 2.1%
34
51
Company Overview

Sales
22.7 Cr
Growth: 20.0%
Profit after Tax
-3.41 Cr
Growth: -25.3%
Micro Cap
15.1 Cr
P/S: 0.7x
Industry P/S: 3.1x
Fundamentals

Sales (Cr) ₹ 22.7
Growth 20.0%
EBITDA -5.5%
P/S 0.7x
Dividend 0.0%
P/E -4.4x
Book Value ₹ -2.6
PEG Ratio -0.2x
ROE 753.6%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Parmax Pharma was incorporated on November 02, 1994. The certificate of commencement of business was received by the company on March 10, 1995.The IPO of the company was January 30, 1996 with 5100800 shares of Rs10/-each. The promoters were earlier in manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The company then discontinued its business activities for few years due to various reasons.
Investors (3)